158 related articles for article (PubMed ID: 29195127)
61. Prospective study of natural cytotoxicity in peripheral blood of patients with nonlymphoid solid malignancies.
Stewart LD; Ades EW
Clin Immunol Immunopathol; 1984 Apr; 31(1):78-86. PubMed ID: 6697576
[TBL] [Abstract][Full Text] [Related]
62. Active Estrogen-Succinate Metabolism Promotes Heme Accumulation and Increases the Proliferative and Invasive Potential of Endometrial Cancer Cells.
Lu JJ; Zhang X; Abudukeyoumu A; Lai ZZ; Hou DY; Wu JN; Tao X; Li MQ; Zhu XY; Xie F
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509133
[TBL] [Abstract][Full Text] [Related]
63. The effect of surgery and chemotherapy on blood NK cell activity in patients with ovarian cancer.
Lukomska B; Olszewski WL; Engeset A; Kolstad P
Cancer; 1983 Feb; 51(3):465-9. PubMed ID: 6401589
[TBL] [Abstract][Full Text] [Related]
64. Modulation of cisPlatin cytotoxicity by interleukin-1 alpha and resident tumor macrophages.
Braunschweiger PG; Basrur VS; Cameron D; Sharpe L; Santos O; Perras JP; Sevin BU; Markoe AM
Biotherapy; 1997; 10(2):129-37. PubMed ID: 9373735
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of Changes in the Expression Profile of mRNA and Proteinencoding Adiponectin in Ishikawa Cell Line under the Influence of Cisplatin - Preliminary Report.
Kiełabsiński R; Kieszkowski P; Grabarek BO; Boroń D
Curr Pharm Biotechnol; 2020; 21(12):1242-1248. PubMed ID: 32370713
[TBL] [Abstract][Full Text] [Related]
66. The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity.
Girone C; Calati F; Lo Cigno I; Salvi V; Tassinari V; Schioppa T; Borgogna C; Lospinoso Severini L; Hiscott J; Cerboni C; Soriani A; Bosisio D; Gariglio M
Cancer Immunol Immunother; 2023 Sep; 72(9):3097-3110. PubMed ID: 37356050
[TBL] [Abstract][Full Text] [Related]
67. Mechanisms of Cisplatin in Combination with Repurposed Drugs against Human Endometrial Carcinoma Cells.
Lin CK; Liu ST; Wu ZS; Wang YC; Huang SM
Life (Basel); 2021 Feb; 11(2):. PubMed ID: 33669781
[TBL] [Abstract][Full Text] [Related]
68. Reduced natural cytotoxic cell activity in patients receiving cisplatin-based chemotherapy and in mice treated with cisplatin.
Powell CB; Mutch DG; Kao MS; Collins JL
Clin Exp Immunol; 1990 Mar; 79(3):424-9. PubMed ID: 2317947
[TBL] [Abstract][Full Text] [Related]
69. Synergistic Growth Inhibitory Effects of Eryngium kotschyi Extracts with Conventional Cytotoxic Agents: Cisplatin and Doxorubicin against Human Endometrium Cancer Cells.
Karaboğa Arslan AK; Paşayeva L; Esen MA; Tugay O
Curr Pharm Biotechnol; 2022; 23(5):740-748. PubMed ID: 34445948
[TBL] [Abstract][Full Text] [Related]
70. CCDC68 Upregulation by IL-6 Promotes Endometrial Carcinoma Progression.
Li X; Li H; Pei X; Zhou Y; Wei Z
J Interferon Cytokine Res; 2021 Jan; 41(1):12-19. PubMed ID: 33471616
[TBL] [Abstract][Full Text] [Related]
71. Protopanaxadiol and metformin synergistically inhibit estrogen-mediated proliferation and anti-autophagy effects in endometrial cancer cells.
Gu CJ; Cheng J; Zhang B; Yang SL; Xie F; Sun JS; Huang LQ; Yu JJ; Li MQ
Am J Transl Res; 2017; 9(9):4071-4082. PubMed ID: 28979682
[TBL] [Abstract][Full Text] [Related]
72. Multi-targeting liposomal codelivery of cisplatin and rapamycin inhibits pancreatic cancer growth and metastasis through stromal modulation.
Zhu W; Yu H; Jia M; Lin C; Yuan Z; Tan X; Yan P
Int J Pharm; 2023 Sep; 644():123316. PubMed ID: 37586573
[TBL] [Abstract][Full Text] [Related]
73. Effect of cisplatin upon expression of in vivo immune tumor resistance.
Crum ED
Cancer Immunol Immunother; 1993; 36(1):18-24. PubMed ID: 8422664
[TBL] [Abstract][Full Text] [Related]
74. Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs.
Kozlowska AK; Topchyan P; Kaur K; Tseng HC; Teruel A; Hiraga T; Jewett A
J Cancer; 2017; 8(4):537-554. PubMed ID: 28367234
[TBL] [Abstract][Full Text] [Related]
75. Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells.
Ono M; Miyamoto T; Fuseya C; Asaka R; Ando H; Tanaka Y; Shinagawa M; Yokokawa Y; Takeuchi H; Horiuchi A; Shiozawa T
Discov Oncol; 2023 Jan; 14(1):9. PubMed ID: 36689027
[TBL] [Abstract][Full Text] [Related]
76. Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury.
Zhou Q; Doherty J; Akk A; Springer LE; Fan P; Spasojevic I; Halade GV; Yang H; Pham CTN; Wickline SA; Pan H
Nanomaterials (Basel); 2022 Jan; 12(3):. PubMed ID: 35159680
[TBL] [Abstract][Full Text] [Related]
77. Corrigendum to "Systematic combination screening reveals synergism between rapamycin and sutent against human lung cancer" [Cancer Letter 342(2014) 159-166].
Li X; Tong LJ; Ding J; Meng LH
Cancer Lett; 2020 Feb; 470():220. PubMed ID: 31818678
[No Abstract] [Full Text] [Related]
78. Autophagy in the physiological endometrium and cancer.
Devis-Jauregui L; Eritja N; Davis ML; Matias-Guiu X; Llobet-Navàs D
Autophagy; 2021 May; 17(5):1077-1095. PubMed ID: 32401642
[TBL] [Abstract][Full Text] [Related]
79. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract][Full Text] [Related]
80. Rapamycin prevents spontaneous abortion by triggering decidual stromal cell autophagy-mediated NK cell residence.
Lu H; Yang HL; Zhou WJ; Lai ZZ; Qiu XM; Fu Q; Zhao JY; Wang J; Li DJ; Li MQ
Autophagy; 2021 Sep; 17(9):2511-2527. PubMed ID: 33030400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
